2024-09-302026-03-312026-03-31false15985490NIEVE DENTAL & AESTHETICS LIMITED2026-09-29falseiso4217:GBPxbrli:pure159854902024-09-29159854902026-03-31159854902024-09-302026-03-31159854902024-09-28159854902024-09-29159854902024-09-292024-09-2915985490bus:SmallEntities2024-09-302026-03-3115985490bus:AuditExempt-NoAccountantsReport2024-09-302026-03-3115985490bus:AbridgedAccounts2024-09-302026-03-3115985490bus:PrivateLimitedCompanyLtd2024-09-302026-03-3115985490core:WithinOneYear2026-03-3115985490core:AfterOneYear2026-03-3115985490core:WithinOneYear2024-09-2915985490core:AfterOneYear2024-09-2915985490core:ShareCapital2026-03-3115985490core:SharePremium2026-03-3115985490core:RevaluationReserve2026-03-3115985490core:OtherReservesSubtotal2026-03-3115985490core:RetainedEarningsAccumulatedLosses2026-03-3115985490core:ShareCapital2024-09-2915985490core:SharePremium2024-09-2915985490core:RevaluationReserve2024-09-2915985490core:OtherReservesSubtotal2024-09-2915985490core:RetainedEarningsAccumulatedLosses2024-09-2915985490core:LandBuildings2026-03-3115985490core:PlantMachinery2026-03-3115985490core:Vehicles2026-03-3115985490core:FurnitureFittings2026-03-3115985490core:OfficeEquipment2026-03-3115985490core:NetGoodwill2026-03-3115985490core:IntangibleAssetsOtherThanGoodwill2026-03-3115985490core:ListedExchangeTraded2026-03-3115985490core:UnlistedNon-exchangeTraded2026-03-3115985490core:LandBuildings2024-09-2915985490core:PlantMachinery2024-09-2915985490core:Vehicles2024-09-2915985490core:FurnitureFittings2024-09-2915985490core:OfficeEquipment2024-09-2915985490core:NetGoodwill2024-09-2915985490core:IntangibleAssetsOtherThanGoodwill2024-09-2915985490core:ListedExchangeTraded2024-09-2915985490core:UnlistedNon-exchangeTraded2024-09-2915985490core:LandBuildings2024-09-302026-03-3115985490core:PlantMachinery2024-09-302026-03-3115985490core:Vehicles2024-09-302026-03-3115985490core:FurnitureFittings2024-09-302026-03-3115985490core:OfficeEquipment2024-09-302026-03-3115985490core:NetGoodwill2024-09-302026-03-3115985490core:IntangibleAssetsOtherThanGoodwill2024-09-302026-03-3115985490core:ListedExchangeTraded2024-09-302026-03-3115985490core:UnlistedNon-exchangeTraded2024-09-302026-03-3115985490core:MoreThanFiveYears2024-09-302026-03-3115985490core:Non-currentFinancialInstruments2026-03-3115985490core:Non-currentFinancialInstruments2024-09-2915985490dpl:CostSales2024-09-302026-03-3115985490dpl:DistributionCosts2024-09-302026-03-3115985490core:LandBuildings2024-09-302026-03-3115985490core:PlantMachinery2024-09-302026-03-3115985490core:Vehicles2024-09-302026-03-3115985490core:FurnitureFittings2024-09-302026-03-3115985490core:OfficeEquipment2024-09-302026-03-3115985490dpl:AdministrativeExpenses2024-09-302026-03-3115985490core:NetGoodwill2024-09-302026-03-3115985490core:IntangibleAssetsOtherThanGoodwill2024-09-302026-03-3115985490dpl:GroupUndertakings2024-09-302026-03-3115985490dpl:ParticipatingInterests2024-09-302026-03-3115985490dpl:GroupUndertakingscore:ListedExchangeTraded2024-09-302026-03-3115985490core:ListedExchangeTraded2024-09-302026-03-3115985490dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-09-302026-03-3115985490core:UnlistedNon-exchangeTraded2024-09-302026-03-3115985490dpl:CostSales2024-09-292024-09-2915985490dpl:DistributionCosts2024-09-292024-09-2915985490core:LandBuildings2024-09-292024-09-2915985490core:PlantMachinery2024-09-292024-09-2915985490core:Vehicles2024-09-292024-09-2915985490core:FurnitureFittings2024-09-292024-09-2915985490core:OfficeEquipment2024-09-292024-09-2915985490dpl:AdministrativeExpenses2024-09-292024-09-2915985490core:NetGoodwill2024-09-292024-09-2915985490core:IntangibleAssetsOtherThanGoodwill2024-09-292024-09-2915985490dpl:GroupUndertakings2024-09-292024-09-2915985490dpl:ParticipatingInterests2024-09-292024-09-2915985490dpl:GroupUndertakingscore:ListedExchangeTraded2024-09-292024-09-2915985490core:ListedExchangeTraded2024-09-292024-09-2915985490dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-09-292024-09-2915985490core:UnlistedNon-exchangeTraded2024-09-292024-09-2915985490core:NetGoodwill2026-03-3115985490core:IntangibleAssetsOtherThanGoodwill2026-03-3115985490core:LandBuildings2026-03-3115985490core:PlantMachinery2026-03-3115985490core:Vehicles2026-03-3115985490core:FurnitureFittings2026-03-3115985490core:OfficeEquipment2026-03-3115985490core:AfterOneYear2026-03-3115985490core:WithinOneYear2026-03-3115985490core:ListedExchangeTraded2026-03-3115985490core:UnlistedNon-exchangeTraded2026-03-3115985490core:ShareCapital2026-03-3115985490core:SharePremium2026-03-3115985490core:RevaluationReserve2026-03-3115985490core:OtherReservesSubtotal2026-03-3115985490core:RetainedEarningsAccumulatedLosses2026-03-3115985490core:NetGoodwill2024-09-2915985490core:IntangibleAssetsOtherThanGoodwill2024-09-2915985490core:LandBuildings2024-09-2915985490core:PlantMachinery2024-09-2915985490core:Vehicles2024-09-2915985490core:FurnitureFittings2024-09-2915985490core:OfficeEquipment2024-09-2915985490core:AfterOneYear2024-09-2915985490core:WithinOneYear2024-09-2915985490core:ListedExchangeTraded2024-09-2915985490core:UnlistedNon-exchangeTraded2024-09-2915985490core:ShareCapital2024-09-2915985490core:SharePremium2024-09-2915985490core:RevaluationReserve2024-09-2915985490core:OtherReservesSubtotal2024-09-2915985490core:RetainedEarningsAccumulatedLosses2024-09-2915985490core:NetGoodwill2024-09-2815985490core:IntangibleAssetsOtherThanGoodwill2024-09-2815985490core:LandBuildings2024-09-2815985490core:PlantMachinery2024-09-2815985490core:Vehicles2024-09-2815985490core:FurnitureFittings2024-09-2815985490core:OfficeEquipment2024-09-2815985490core:AfterOneYear2024-09-2815985490core:WithinOneYear2024-09-2815985490core:ListedExchangeTraded2024-09-2815985490core:UnlistedNon-exchangeTraded2024-09-2815985490core:ShareCapital2024-09-2815985490core:SharePremium2024-09-2815985490core:RevaluationReserve2024-09-2815985490core:OtherReservesSubtotal2024-09-2815985490core:RetainedEarningsAccumulatedLosses2024-09-2815985490core:AfterOneYear2024-09-302026-03-3115985490core:WithinOneYear2024-09-302026-03-3115985490core:Non-currentFinancialInstrumentscore:CostValuation2024-09-302026-03-3115985490core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-302026-03-3115985490core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-302026-03-3115985490core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-302026-03-3115985490core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-302026-03-3115985490core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-302026-03-3115985490core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-302026-03-3115985490core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-302026-03-3115985490core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-302026-03-3115985490core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3115985490core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3115985490core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3115985490core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3115985490core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3115985490core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3115985490core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3115985490core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3115985490core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3115985490core:Non-currentFinancialInstrumentscore:CostValuation2024-09-2915985490core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-2915985490core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-2915985490core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-2915985490core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-2915985490core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-2915985490core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-2915985490core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-2915985490core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-2915985490bus:Director12024-09-302026-03-3115985490bus:Director22024-09-302026-03-31

NIEVE DENTAL & AESTHETICS LIMITED

Registered Number
15985490
(England and Wales)

Unaudited Financial Statements for the Period ended
31 March 2026

NIEVE DENTAL & AESTHETICS LIMITED
Company Information
for the period from 30 September 2024 to 31 March 2026

Directors

FAURA, Ieva
MAJUMDAR, Neeru, Dr

Registered Address

Fulford Lodge
1 Heslington Lane
York
YO10 4HN

Registered Number

15985490 (England and Wales)
NIEVE DENTAL & AESTHETICS LIMITED
Statement of Financial Position
31 March 2026

Notes

2026

£

£

Fixed assets
Intangible assets3526,686
Tangible assets59,478
536,164
Current assets
Stocks3,302
Debtors63,805
Cash at bank and on hand76,874
143,981
Creditors amounts falling due within one year6(134,493)
Net current assets (liabilities)9,488
Total assets less current liabilities545,652
Creditors amounts falling due after one year7(477,750)
Net assets67,902
Capital and reserves
Called up share capital100
Profit and loss account67,802
Shareholders' funds67,902
The financial statements were approved and authorised for issue by the Board of Directors on 29 September 2026, and are signed on its behalf by:
FAURA, Ieva
Director
MAJUMDAR, Neeru, Dr
Director

Registered Company No. 15985490
NIEVE DENTAL & AESTHETICS LIMITED
Notes to the Financial Statements
for the period ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Basis of preparation
The financial statements have been prepared on the historical cost basis.
Functional and presentation currency
The financial statements are presented in sterling, which is the functional currency of the entity.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
Defined contribution pension plan
The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.
Current taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amount of tax expected to pay or recover using the tax rates and laws that have been enacted, or substantively enacted, at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted, or substantively enacted, by the reporting date that are expected to apply to the reversal of the timing difference.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Goodwill
Goodwill arising on an acquisition of a business is carried at cost less accumulated impairment losses, if any. Goodwill is amortised over its expected useful life which is estimated to be ten years. Goodwill is assessed for impairment when there are indicators of impairment and any impairment is charged to the income statement. No reversals of impairment are recognised.
Tangible fixed assets and depreciation
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Stocks and work in progress
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all cost of purchase, cost of conversion and other costs incurred in bringing the stock to its present location and condition.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2.Average number of employees

2026
Average number of employees during the year0
3.Intangible assets

Total

£
Cost or valuation
Additions526,686
At 31 March 26526,686
Net book value
At 31 March 26526,686
At 29 September 24-
4.Useful life of intangible assets
As there is an active market for dental practices, amortisation has not been charged on the goodwill held by the company.
5.Tangible fixed assets

Total

£
Cost or valuation
Additions11,897
At 31 March 2611,897
Depreciation and impairment
Charge for year2,419
At 31 March 262,419
Net book value
At 31 March 269,478
At 29 September 24-
6.Creditors: amounts due within one year

2026

£
Trade creditors / trade payables31,630
Bank borrowings and overdrafts19,394
Taxation and social security16,687
Other creditors62,848
Accrued liabilities and deferred income3,934
Total134,493
7.Creditors: amounts due after one year

2026

£
Bank borrowings and overdrafts477,750
Total477,750
8.Related party transactions
Nieve Dental & Aesthetics Limited operates an intercompany account with Hill Avenue Dental Practice Partnership. The amount owed to the company at the period end was £59,895. Nieve Dental & Aesthetics Limited operates an intercompany account with FJI Herts Limited. FJI Herts Limited owed Nieve Dental & Aesthetics Limited £30,494 at the end of the period. Nieve Dental & Aesthetics Limited operates an intercompany account with N.M. Smile Limited. N.M. Smile Limited owed Nieve Dental & Aesthetics Limited £30,494 at the end of the period.